The Role of Endocrine and Metabolic System in COVID-19 Disease
                    – The Transcampus Experience and Review of Evidence From International
                    Collaborating Groups

Nikolaos Perakakis; Andreas Barthel; Stefan R. Bornstein

doi:10.1055/a-1873-2300

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2022; 54(08): 494-495
DOI: 10.1055/a-1873-2300

Editorial

The Role of Endocrine and Metabolic System in COVID-19 Disease – The Transcampus Experience and Review of Evidence From International Collaborating Groups

Authors

Nikolaos Perakakis

¹Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

²Paul Langerhans Institute Dresden (PLID), Helmholtz Center Munich, University Hospital and Faculty of Medicine, TU Dresden, Dresden, Germany

³German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
Andreas Barthel

¹Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

⁴Medicover Bochum, Bochum, Germany
Stefan R. Bornstein

¹Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

⁵Division of Endocrinology, Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK

⁶Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland

Abstract

The COVID-19 Pandemic has led to a world health crisis with major socioeconomic consequences that have deeply affected our daily lives. Until the end of May 2022, more than 500 million people have been infected by COVID-19 and more than 6 million have died from the disease. Unprecedented efforts in research, illustrated by the more than 250 000 publications in PubMed, have led to the identification of important pathophysiological mechanisms affected by SARS-CoV-2 and have resulted in the development of effective vaccines and treatment protocols for patients with COVID-19.

Full Text

References

References
1 Steenblock C, Hassanein M, Khan E. et al. Obesity and COVID-19: What are the consequences?. Horm Metab Res 2022; 54: 496-502
2 Steenblock C, Hassanein M, Khan E. et al. Diabetes and COVID-19: Short- and long-term consequences. Horm Metab Res 2022; 54: 503-509
3 Maremonti F, Locke S, Tonnus W. et al. COVID-19 and diabetic nephropathy. Horm Metab Res 2022; 54: 510-513
4 Julius U, Schatz U, Tselmin S. et al. COVID-19 and lipid disorders. Horm Metab Res 2022; 54: 514-521
5 Hoffmann C, Gerber PA, Cavelti-Weder C. et al. Liver, NAFLD and COVID-19. Horm Metab Res 2022; 54: 522-531
6 Kanczkowski W, Gaba WH, Krone N. et al. Adrenal gland function and dysfunction during COVID-19. Horm Metab Res 2022; 54: 532-539
7 Tsourdi E, Hofbauer LC, Rauner M. The impact of COVID-19 in bone metabolism: basic and clinical aspects. Horm Metab Res 2022; 54: 540-548
8 Bechmann N, Maccio U, Kotb R. COVID-19 infections in gonads: consequences on fertility?. Horm Metab Res 2022; 54: 549-555
9 Kurtulmus N, Kayikci K. Subacute thyroiditis following SARS-CoV-2 vaccines: Six cases report and review of the literature. Horm Metab Res 2022; 54: 556-561
10 Bornstein SR, Cozma D, Kamel M. et al. Long-COVID, metabolic and endocrine disease. Horm Metab Res 2022; 54: 562-566
11 Rohner M, Schwarz PE, Bornstein SR. Treating insulin resistance with intermittent personalized nutrition to sustain metabolic health and functioning immune system for risk reduction of viral diseases especially COVID-19 and long-COVID. Horm Metab Res 2022; 54: 567-570
12 Tselmin S, Julius U, Jarzebska N. et al. COVID-19 and therapeutic apheresis. Horm Metab Res 2022; 54: 571-577